Dexcom will stop producing G6 CGM sensors July 1, 2026, urging patients to switch to the smaller, more accurate G7 model.

Dexcom (Nasdaq:DXCM) today announced its plans to share new data supporting its diabetes management technology at ATTD 2026.

(NASDAQ:DXCM), the global leader in glucose biosensing, will present new findings that showcase the benefits of its glucose biosensing technology for people with all types of diabetes and share more ...

BTIG analysts continue to expect growth from Dexcom (Nasdaq:DXCM) after meeting with the company's senior investor relations (IR) officials.

Macron to host G7 leaders call on Iran crisis, energy prices French President Emmanuel Macron will convene a call with leaders of the Group of ‌Seven on Wednesday to discuss the Iran crisis and rising ...

New data show that wearable neuromodulation can be used with CGMs without disrupting glucose accuracy or connectivity.